Comparative Effectiveness of Intravenous Immunoglobulin (IVIg) and Subcutaneous Immunoglobulin (SCIg) versus Historical controls in Management of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Authors

  • Mamatha Pasnoor MD
  • Mazen M. Dimachkie MD
  • Byron Gajewski PhD
  • Lemuel R. Waitman PhD
  • Kim Kimminau PhD
  • Richard J. Barohn MD
  • Andrew Heim BSc

DOI:

https://doi.org/10.17161/rrnmf.v2i3.15706

Keywords:

IVIg, SCIg, CIDP, Grant

Metrics

Metrics Loading ...

Downloads

Download data is not yet available.
2 images; one of a man in a backwards baseball cap on a cell phone, and a second image of a woman on a cell phone

Downloads

Published

2021-08-03

Issue

Vol. 2 No. 3 (2021)

Section

Grant proposals (Funded or unfunded)

License

Copyright (c) 2021 Mamatha Pasnoor MD, Mazen M Dimachkie MD, Byron Gajewski PhD, Lemuel Russell Waitman PhD, Kim Kimminau PhD, Richard Barohn MD, Andrew Heim BSc

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

How to Cite

Pasnoor, M., Dimachkie, M. M., Gajewski, B., Waitman , L. ., Kimminau, K. ., Barohn, R. J., & Heim, A. (2021). Comparative Effectiveness of Intravenous Immunoglobulin (IVIg) and Subcutaneous Immunoglobulin (SCIg) versus Historical controls in Management of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) . RRNMF Neuromuscular Journal, 2(3), 60-103. https://doi.org/10.17161/rrnmf.v2i3.15706